---
ver: rpa2
title: 'Open Foundation Models in Healthcare: Challenges, Paradoxes, and Opportunities
  with GenAI Driven Personalized Prescription'
arxiv_id: '2502.04356'
source_url: https://arxiv.org/abs/2502.04356
tags:
- llms
- medical
- arxiv
- healthcare
- open
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: The study investigates the use of open-source Large Language Models
  (LLMs) and AI Foundation Models (AIFMs) for healthcare applications, specifically
  personalized prescription analysis. It introduces a taxonomy of open AIFMs and evaluates
  their performance against proprietary models in identifying adverse drug reactions.
---

# Open Foundation Models in Healthcare: Challenges, Paradoxes, and Opportunities with GenAI Driven Personalized Prescription

## Quick Facts
- arXiv ID: 2502.04356
- Source URL: https://arxiv.org/abs/2502.04356
- Reference count: 40
- Key finding: Open-source models like LLaMA-3 can match proprietary models like GPT-4 in healthcare prescription analysis when augmented with RAG

## Executive Summary
This study investigates the application of open-source Large Language Models (LLMs) and AI Foundation Models (AIFMs) for personalized prescription analysis in healthcare. The research introduces a comprehensive taxonomy of open AIFMs and evaluates their performance in identifying adverse drug reactions, comparing them against proprietary models. A key innovation is demonstrating that open-source models can achieve comparable performance to proprietary alternatives like GPT-4 when augmented with Retrieval-Augmented Generation (RAG). The study employs both quantitative metrics and expert clinician validation to assess model performance and clinical relevance.

## Method Summary
The research employs a mixed-methods approach combining quantitative evaluation metrics with qualitative expert assessment. The study introduces a taxonomy of open AIFMs and tests their performance in personalized prescription analysis, specifically focusing on adverse drug reaction identification. Models are evaluated using standard metrics including accuracy, precision, recall, and F1-score, with additional validation from expert clinicians to assess clinical relevance. The research compares open-source models against proprietary alternatives and examines the impact of RAG augmentation on performance.

## Key Results
- Open-source models like LLaMA-3 achieve comparable performance to proprietary models like GPT-4 when augmented with RAG
- RAG augmentation significantly improves the performance of open-source models in healthcare contexts
- Expert clinician validation confirms the clinical relevance of model recommendations

## Why This Works (Mechanism)
The effectiveness of open-source models in healthcare applications stems from their ability to leverage external knowledge bases through RAG augmentation, compensating for potential knowledge gaps. This approach allows open models to access up-to-date medical information and clinical guidelines, bridging the performance gap with proprietary models that may have larger internal knowledge bases. The combination of model architecture and external retrieval creates a hybrid system that can provide accurate, context-aware recommendations for personalized prescription analysis.

## Foundational Learning
- **LLM Architecture**: Understanding transformer-based models is crucial for implementing and fine-tuning healthcare applications
  - Why needed: Provides foundation for model customization and optimization
  - Quick check: Verify model architecture matches healthcare requirements

- **RAG Augmentation**: Knowledge retrieval systems enhance model performance by providing external context
  - Why needed: Addresses knowledge limitations in open-source models
- **Clinical Validation**: Expert assessment ensures model recommendations are medically sound
  - Why needed: Guarantees clinical relevance and safety
  - Quick check: Compare model outputs against clinical guidelines

## Architecture Onboarding

Component map: Patient Data -> Feature Extraction -> RAG Retrieval -> Model Processing -> Recommendation Output

Critical path: Data Input → Feature Extraction → Knowledge Retrieval → Model Inference → Clinical Validation

Design tradeoffs: Model size vs. inference speed, knowledge base comprehensiveness vs. retrieval accuracy, clinical precision vs. generalization

Failure signatures: Incorrect drug interactions, outdated medical information, contextual misunderstandings in patient-specific scenarios

First experiments:
1. Baseline performance comparison between open-source and proprietary models without RAG
2. RAG configuration optimization with different knowledge base sizes
3. Clinical relevance assessment with varying levels of expert input

## Open Questions the Paper Calls Out
The paper highlights several open questions regarding the generalizability of results across different clinical contexts and patient populations, the optimal configuration of RAG systems for healthcare applications, and the long-term reliability of open-source models in critical medical decision-making scenarios.

## Limitations
- Results may not generalize across diverse clinical contexts and patient populations
- Expert clinician assessment introduces subjectivity that varies between practitioners
- Narrow focus on adverse drug reactions limits broader applicability conclusions

## Confidence
- **High confidence**: Technical implementation of RAG augmentation and its positive impact
- **Medium confidence**: Comparative performance metrics between open and proprietary models
- **Low confidence**: Generalizability to real-world clinical settings and diverse populations

## Next Checks
1. Conduct multi-center clinical validation with diverse patient demographics
2. Perform ablation studies comparing different RAG retrieval strategies
3. Implement longitudinal studies tracking patient outcomes with model recommendations